Medicare Wants to Limit Biogen's Alzheimer's Drug Aduhelm to Trial Participants
The guidance is a blow for Biogen, which has struggled with sales of its new drug after a controversial FDA approval.
Source: businessinsider.com
Page 27 - Aduhelm News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Aduhelm. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Aduhelm Today - Breaking & Trending Today
Medicare Limits Coverage of $28,000-A-Year Alzheimer's Drug
Medicare says it will limit coverage of a $28,000-a-year Alzheimer’s drug whose benefits have been widely questioned
Source: nbcdfw.com
Medicare told to reassess premium hike for Alzheimer's drug
More than 50 million Medicare recipients who pay the $170.10 monthly “Part B” premium for outpatient care will see no immediate change to their costs, but Monday’s move could open the way for a reduction later in the year.
Source: kxxv.com
Medicare told to reassess premium hike for Alzheimer's drug
WASHINGTON (AP) — U.S. health secretary Xavier Becerra on Monday ordered Medicare to...
Source: middletownpress.com
Medicare told to reassess premium hike for Alzheimer's drug
WASHINGTON (AP) — U.S. health secretary Xavier Becerra on Monday ordered Medicare to...
Source: ctinsider.com